The global diabetes devices market size is expected to reach USD 35.5
billion by 2024, according to a new report by Grand View Research, Inc. The
market is projected to expand at a CAGR of 7.0% during the forecast period.
Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles,
and several other factors, is expected to drive demand for diabetes devices
over the next few years.
Obesity is believed to be one of the foremost factors leading to
diabetes in individuals. According to WHO, in 2014, over 1.9 billion people
were identified to be overweight, of which, around 600 million people were
obese.
Some of the key companies in the global diabetes devices market are
Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company,
Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson
& Johnson.
Full Research Report On Diabetes Devices Market Analysis:
https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market
https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market
Further key findings from the study suggest:
·
Constantly rising target population base is
the primary factor driving market growth
·
Test strips capturedthe largest share in
the monitoring and diagnostics device segment while insulin pens accounted for
the largest revenue share among insulin delivery devices in 2016. This can be
attributed to rapid adoption of these user-friendly, quick, and accurate
devices for homecare use
·
North America is leading the regional
market, followed by Europe. Advanced healthcare infrastructure and availability
of technologically advanced products have driven the regional market
·
Key players in the market include Medtronic
PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo
Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson &
Johnson.
View More Reports
Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global diabetes devices market on
the basis of product type and region:
Diabetes Devices Product Type
Outlook (Revenue, USD Million, 2014 - 2024)
·
Monitoring and Diagnostic Devices
o Lancets
o Analog Glucose Monitor
o Continuous Glucose Monitor
o Test Strips
·
Insulin Delivery Devices
o Syringe
o Pens
o Pumps
o Injectors
Diabetes Devices Regional
Outlook (Revenue, USD Million, 2014 - 2024)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o China
o India
·
Latin America
o Mexico
o Brazil
·
MEA
o UAE
Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-diabetes-devices-market
https://www.grandviewresearch.com/press-release/global-diabetes-devices-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/
No comments:
Post a Comment